Public Health


17 November 2021

Today, the European Commission published an implementation roadmap and progress indicators for Europe’s Beating Cancer Plan to monitor progress on the ten flagship initiatives as well as its other ambitious actions.

28 October 2021

New pilot project for not-for-profit organisations, academia on repurposing medicines for additional uses. This will increase access to affordable medicines, a major pillar of our Pharmaceutical Strategy.

22 October 2021

These therapeutics will bring treatment to patients across the EU as fast as possible provided that their safety and effectiveness has been confirmed by the European Medicines Agency.

22 October 2021

The Conference on the Future of Europe is a citizen-led series of debates and discussions that will enable people from across Europe to share their ideas and help shape our common future.

14 October 2021

The European Commission has requested the EXPH to provide an opinion on how to best offer mental health support to the health workforce and other essential workers.

14 October 2021

Today, the European Commission has proposed a progressive roll-out of the new In Vitro Diagnostic Medical Devices Regulation to prevent disruption in the supply of these essential healthcare products.

12 October 2021

Independent experts are needed for the SCHEER working group to produce an updated Opinion on the safety of Electromagnetic fields (EMF), as requested by the European Commission. Apply by 14 November 2021.

30 September 2021

The European Commission launches the 2021 EU Health Award on the following topics: cancer prevention and mental health. Interested parties are invited to participate by 30 November 2021.

28 September 2021
Today, as part of its work to create a future-proof and crisis-resilient regulatory framework for the pharmaceutical sector, the Commission has published a public consultation on the revision of the EU's pharmaceutical legislation.
23 September 2021

Following the launch of HERA earlier this month, work is now beginning in earnest on some of its key activities such as mapping, manufacturing, stockpiling and bringing medical countermeasures to market.